Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Safety of High-Volume Plasmapheresis in Children With Acute Liver Failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Extended Screening for Cystic Fibrosis Related Liver Disease Including Elastography Inchildren and Adolescents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Preterm Birth Has Effects on Gut Colonization in Piglets Within the First 4 Weeks of Life

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Bovine Colostrum For Preterm Infants in the First Days of Life: A Randomized Controlled Pilot Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Effect of Probiotics on Diarrhea in Children With Severe Acute Malnutrition: A Randomized Controlled Study in Uganda

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Kongenitte portosystemiske shunter, diagnose og behandling af en multisystemisk sygdom hos børn

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Bacterial and fungal bloodstream infections in pediatric liver and kidney transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVES: Paediatric acute liver failure (P-ALF) is a rare condition and is associated with a high mortality rate. Management of P-ALF aims to stabilise vital organ functions and to remove circulating toxins and provide vital plasma factors that are lacking. High-volume plasmapheresis (HVP) removes protein-bound substances and improves survival in adult ALF. It is unknown if this effect can be extrapolated to P-ALF. The aim of this study is to report the safety and feasibility of HVP in P-ALF.

METHODS: Children with P-ALF were offered HVP if bilirubin was higher than 200 μmol/L or if the aetiology was toxic hepatitis. HVP was performed with fresh frozen plasma corresponding to 10% of the body weight on a minimum of 3 consecutive days. Diagnostics, biochemical and clinical data during HVP as well as outcome data after 3 months were collected from 2012 to 2019 and retrospectively analysed.

RESULTS: Sixteen children were treated by HVP and completed at least one series of three treatment sessions with HVP. The only complication seen was an increase in pH > 7.55 in three children within the first 12 hours and was corrected with hydrochloric acid. No bleeding or septic episodes were noted during HVP. Eight children survived without liver transplantation, two survived after successful grafting and a total of six children died. The liver injury unit score between survivors with their own liver and the rest, the two groups was significantly different (P = 0.005).

CONCLUSION: HVP with fresh frozen plasma is feasible and well tolerated in children with P-ALF. No serious adverse events and no procedure-related mortality were observed.

OriginalsprogEngelsk
TidsskriftJournal of Pediatric Gastroenterology and Nutrition
Vol/bind72
Udgave nummer6
Sider (fra-til)815-819
Antal sider5
ISSN0277-2116
DOI
StatusUdgivet - 1 jun. 2021

ID: 63752900